Ionis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
IONS Key Statistics
Stock Snapshot
As of today, Ionis Pharmaceuticals(IONS) shares are valued at $80.30. The company's market cap stands at 13.02B, with a P/E ratio of -46.92.
On 2026-01-11, Ionis Pharmaceuticals(IONS) stock moved within a range of $79.30 to $83.23. With shares now at $80.30, the stock is trading +1.3% above its intraday low and -3.5% below the session's peak.
Trading volume for Ionis Pharmaceuticals(IONS) stock has reached 2.67M, versus its average volume of 1.82M.
The stock's 52-week range extends from a low of $23.95 to a high of $86.15.
The stock's 52-week range extends from a low of $23.95 to a high of $86.15.
IONS News
GSK and Ionis Pharmaceuticals recently reported that their experimental hepatitis B therapy bepirovirsen met primary endpoints in two Phase 3 trials, achieving...
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) partner GSK Plc (NYSE:GSK) on Wednesday shared data from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, of bepirov...
Ionis Pharmaceuticals (IONS) partner GSK (GSK) announced results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the safety and efficacy of...
Analyst ratings
71%
of 24 ratingsMore IONS News
Recent optimism from several Wall Street firms toward Ionis Pharmaceuticals (IONS) has been tied to its broad RNA-focused pipeline and the recent FDA approval o...
Wells Fargo raised the firm’s price target on Ionis Pharmaceuticals (IONS) to $100 from $82 and keeps an Overweight rating on the shares. Following a strong 202...